Publication | Closed Access

CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study

Lymphoid NeoplasiaImmunologyCell TransplantationImmune Cell TherapyImmunotherapyMedicineCell BiologyPhase 1Genome EditingAdult T-cell Leukemia-lymphomaLarge B-cell Lymphoma